A detailed history of First National Bank Sioux Falls transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First National Bank Sioux Falls holds 11,195 shares of BMY stock, worth $595,462. This represents 0.24% of its overall portfolio holdings.

Number of Shares
11,195
Previous 11,195 -0.0%
Holding current value
$595,462
Previous $607,000 23.56%
% of portfolio
0.24%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $46,224 - $54,735
-675 Reduced 5.69%
11,195 $0
Q3 2022

Oct 14, 2022

SELL
$0.13 - $76.84 $104 - $61,472
-800 Reduced 6.31%
11,870 $844,000
Q4 2021

Jan 25, 2022

BUY
$53.63 - $62.52 $300,328 - $350,112
5,600 Added 79.21%
12,670 $790,000
Q3 2021

Oct 15, 2021

BUY
$59.17 - $69.31 $236,680 - $277,240
4,000 Added 130.29%
7,070 $418,000
Q2 2021

Jul 19, 2021

BUY
$61.91 - $67.42 $190,063 - $206,979
3,070 New
3,070 $205,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First National Bank Sioux Falls Portfolio

Follow First National Bank Sioux Falls and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Sioux Falls, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Sioux Falls with notifications on news.